China AI drug-design deals swell as US scrutiny mounts
Riding a wave of booming cross-border dealmaking, China’s AI-driven drug-design firms are charging onto the global stage despite…
China AI drug-design deals swell as US scrutiny mounts
Riding a wave of booming cross-border dealmaking, China’s AI-driven drug-design firms are charging onto the global stage despite…
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments
A Merck & Co. researcher at work. Merck will partner with Protillion Biosciences to discover multiple new therapy…
Q&A: Owkin’s five-year Sanofi deal bets on ‘purpose-built’ AI agents
Image from Owkin Over the past two years, software engineering has handed a growing share of its routine…
AstraZeneca Turns to AI Agent to Cut Drug Discovery Time
Artificial Intelligence & Machine Learning , Healthcare , Industry Specific Owkin AI Will Analyze Trials, Forecasts, Other Rival…
Owkin To Build AI Agents As Part Of Multi-Year K Pro License Agreement With AstraZeneca
Owkin, the agentic AI company focused on drug discovery and development, has announced an agreement with AstraZeneca to…